NextGen · Task 7.4 cost-benefit model
KI use-case CBA calculator
Compare the costs and benefits of one KI tool with today's pathway, over a fixed horizon. Choose a use case, then replace the placeholder inputs with sourced figures.
Starting values are illustrative placeholders, not sourced data. Do not use any result until they are replaced.
Net present value
–
PV of benefits
–
PV of costs
–
Benefit-cost ratio
–
Events avoided
–
Hospital days avoided
–
Break-even uptake
–
Year by year
| Year | Discount factor | Events avoided | Benefits | Costs | Net benefit | PV of net |
|---|
Sensitivity: NPV with each input ±20%
| Input | Base value | NPV at −20% | NPV at +20% | Swing |
|---|
Who pays and who gains (Sweden)
Splits the same costs and benefits across the payers in the Swedish system. Shares are placeholders. Each row must add up to 100%.
| Payer | PV of benefits | PV of costs | Net position | Share of direct benefits |
|---|
- Regions (21) run most hospitals and primary care, so they carry most treatment and test costs.
- Municipalities fund elderly and home care. Avoided hospital stays can move cost to them rather than remove it.
- The state funds the drug subsidy under TLV decisions and pays sickness benefit through Försäkringskassan.
- Employers pay sick pay for the early days of an absence. Check the current split.
- Private insurance plays a small role in these cost pools and is not modelled as a payer.
- Verify every share and the discount rate against current TLV, Socialstyrelsen and regional sources before use.
Assumptions: volumes and unit costs stay constant over the horizon, with no ramp-up. Untested patients get no benefit. Patient wellbeing is not monetised unless the QALY option is on. Perspective: Swedish health system (assumed).